Marrone Bio Innovations Inc (NASDAQ: MBII) announced Monday the appointment of Kevin Helash as its new chief executive officer.
Helash replaces Dr Pamela Marrone, founder of Marrone Bio, who announced her intention to retire as CEO in December 2019.
Dr Marrone will remain with the company as CEO until Helash’s first day of employment and will continue to serve as a non-employee director of the company.
Helash, a native of Manitoba, Canada, will join the company as early as August 1, pending receipt of permanent residency status or the applicable visa, both of which are in process. Concurrent with joining the company, Helash also will be appointed as a board director.
READ: Marrone Bio dominates with its flagship Regalia brand emerging as top biofungicide in California
A 28-plus-year agricultural industry veteran, Helash comes to Marrone Bio from Agrinos AS, a global-scale biological crop input provider specializing in biofertilizers and biostimulant products. As CEO of Agrinos since November 2017, Helash led a major restructuring and transformation of the company to create a platform for future long-term growth.
Prior to joining Agrinos, Helash was a vice president and corporate officer with Agrium (now Nutrien Ltd), one of the world’s largest agricultural product distributors. During his 26-year career, he held senior management roles leading global sales, marketing, logistics and supply chain strategies.
“After a comprehensive search process, we are delighted to have someone with Kevin’s extensive experience in the agricultural industry join Marrone Bio as we continue to drive the company toward profitability through a combination of revenue growth, margin expansion and cost management,” said Bob Woods, chairman of the board, in a statement.
“His passion for and leadership in the biologicals space — coupled with his track record of delivering key operational and financial objectives — make him the ideal candidate to take Marrone Bio to its next level of success.”
Helash noted that the company has made significant strides in its commercial operations, driving revenue growth, and gross margin expansion.
“Recent initiatives and R&D advancements have strengthened its position as a unique leader in the biologicals industry, with top-of-mind awareness among growers, distributors and potential partners,” he said.
“In joining Marrone Bio, I will have the good fortune of being surrounded by a great team that is highly versed in agriculture and the key role biologicals play in a more sustainable – and profitable – future for farmers around the world. I look forward to building on a results-oriented, customer-driven culture to achieve our goals as we move along the path to profitability.”
Founded in 2006 in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham
Published at Mon, 06 Jul 2020 20:28:00 +0000-Marrone Bio appoints agricultural industry veteran Kevin Helash as CEO